News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
EU Starts Probe of Danish Drug Group Lundbeck Inc. (formerly Ovation Pharmaceuticals) (JOBS)
January 7, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- European Union antitrust officials said they opened an investigation into possible anticompetitive behaviour by Danish drugmaker Lundbeck (LUN.CO), but the firm said it had not broken any laws.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Lundbeck
MORE ON THIS TOPIC
Insights
The Golden Triangle and the gaps: Rethinking UK biotech
June 25, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Approvals
Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia use
June 25, 2026
·
2 min read
·
Tristan Manalac
Approvals
Gilead’s TROP-2 Trodelvy, Keytruda combo win first-line FDA nods for breast cancer
June 25, 2026
·
1 min read
·
Tristan Manalac
Insights
Labs see rising demand for nitrosamine, topical performance and microbiome testing
June 25, 2026
·
3 min read
·
Jennifer C. Smith-Parker